Format

Send to

Choose Destination
J Invest Dermatol. 2015 Nov;135(11):2572-2576. doi: 10.1038/jid.2015.285. Epub 2015 Aug 13.

The Janus-Faced Role of Aryl Hydrocarbon Receptor Signaling in the Skin: Consequences for Prevention and Treatment of Skin Disorders.

Author information

1
IUF - Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany.
2
IUF - Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany; Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany. Electronic address: jean.krutmann@iuf-duesseldorf.de.

Abstract

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor expressed in all skin cell types, which is critically involved in the pathogenesis of a variety of skin diseases and thus represents a potential therapeutic target. Recent studies indicate that blocking AHR activation is desirable in some skin conditions, whereas the opposite, i.e., stimulation of AHR activation, is beneficial in another group of skin disorders. We here propose a model based on qualitative differences in canonical versus non-canonical AHR signaling to reconcile these seemingly contradictory observations.

PMID:
26269144
DOI:
10.1038/jid.2015.285
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center